Literature DB >> 15225599

Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung.

Vuokko L Kinnula1, Paavo Pääkkö, Ylermi Soini.   

Abstract

Oxidants are known to modulate cell proliferation and apoptosis, and induce synthesis of growth factors that play an important role in tumor growth and invasion. Antioxidant enzymes and thiol proteins regulating cellular redox state constitute the major cellular protection against oxidants. Consequently, they are also associated both with carcinogenesis and tumor progression. Superoxide dismutases, glutamate cysteine ligase, catalase, thioredoxins and peroxiredoxins, which are the most important of these enzymes, are expressed in lung malignancies, and especially in pleural mesothelioma. This has consequences not only for tumor behavior but also for resistance of tumor cells to cytotoxic drugs and radiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225599     DOI: 10.1016/j.febslet.2004.05.045

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression.

Authors:  Chul-Kee Park; Jin Hyun Kim; Min Jeong Moon; Ji Hye Jung; Su-Young Lim; Sung-Hye Park; Jong-Hoon Kim; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho; Sun Ha Paek
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-26       Impact factor: 4.553

2.  Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients.

Authors:  Leonardo Lisbôa da Motta; Carolina B Müller; Marco A De Bastiani; Guilherme A Behr; Fernanda S França; Ricardo F da Rocha; Juliane B Minotto; Rosalva T Meurer; Marilda C Fernandes; Adriana Roehe; Melissa M Markoski; Cristiano F Andrade; Mauro A A Castro; Fábio Klamt
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-22       Impact factor: 4.553

3.  Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy.

Authors:  Hong Jiang; Lisha Wu; Murli Mishra; Hedy A Chawsheen; Qiou Wei
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

4.  Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4-methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes.

Authors:  Brent W Meier; Jose D Gomez; Oleg V Kirichenko; John A Thompson
Journal:  Chem Res Toxicol       Date:  2007-02       Impact factor: 3.739

Review 5.  Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.

Authors:  Irfan Rahman; Vuokko L Kinnula
Journal:  Expert Rev Clin Pharmacol       Date:  2012-05       Impact factor: 5.045

6.  The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.

Authors:  Hedy A Chawsheen; Hong Jiang; Qi Ying; Na Ding; Pratik Thapa; Qiou Wei
Journal:  J Biol Chem       Date:  2019-04-18       Impact factor: 5.157

7.  Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.

Authors:  Terry A Brown-Bryan; Lai S Leoh; Vidya Ganapathy; Fabio J Pacheco; Melanie Mediavilla-Varela; Maria Filippova; Thomas A Linkhart; Rik Gijsbers; Zeger Debyser; Carlos A Casiano
Journal:  Mol Cancer Res       Date:  2008-08       Impact factor: 5.852

8.  Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.

Authors:  Sally Järvelä; Kristiina Nordfors; Miia Jansson; Joonas Haapasalo; Pauli Helén; Leo Paljärvi; Hannu Kalimo; Vuokko Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  J Neurooncol       Date:  2008-08-06       Impact factor: 4.130

9.  Protective Effect of Peroxiredoxin 6 in Ischemia/Reperfusion-Induced Damage of Small Intestine.

Authors:  A E Gordeeva; A A Temnov; A A Charnagalov; M G Sharapov; E E Fesenko; V I Novoselov
Journal:  Dig Dis Sci       Date:  2015-08-02       Impact factor: 3.199

10.  Comparative proteomics analysis of human gastric cancer.

Authors:  Wei Li; Jian-Fang Li; Ying Qu; Xue-Hua Chen; Jian-Min Qin; Qin-Long Gu; Min Yan; Zheng-Gang Zhu; Bing-Ya Liu
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.